Bumper Offer - Urjas oil Just @ Rs. 1
Tellzy 40 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Heart Failure, High BP. Other than this, Tellzy 40 Tablet (15) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Tellzy 40 Tablet (15). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Tellzy 40 Tablet (15) also has some side effects, the most common being Dizziness, Nausea or vomiting, Back Pain. Some other side effects of Tellzy 40 Tablet (15) have been listed ahead. These side effects of Tellzy 40 Tablet (15) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Tellzy 40 Tablet (15) is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Tellzy 40 Tablet (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Tellzy 40 Tablet (15) related warnings section.
Tellzy 40 Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Tellzy 40 Tablet (15) in conditions like Angioedema, Hyperkalemia, Drug Allergy.
Drug interactions for Tellzy 40 Tablet (15) have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Tellzy 40 Tablet (15) is not safe while driving, and is not addiction.
Tellzy 40 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tellzy 40 Tablet (15) is used -
Severe
Mild
Common
Is the use of Tellzy 40 Tablet (15) safe for pregnant women?
Tellzy should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Tellzy 40 Tablet (15) safe during breastfeeding?
Tellzy may have very limited harmful effects for breastfeeding women.
What is the effect of Tellzy 40 Tablet (15) on the Kidneys?
Tellzy is not harmful for kidneys.
What is the effect of Tellzy 40 Tablet (15) on the Liver?
Tellzy may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Tellzy 40 Tablet (15) on the Heart?
Tellzy has very mild side effects on the heart.
Tellzy 40 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tellzy 40 Tablet (15) unless your doctor advises you to do so -
Is this Tellzy 40 Tablet (15) habit forming or addictive?
Tellzy 40 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Tellzy 40 Tablet (15) can make you feel drowsy.
Is it safe?
Tellzy 40 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Tellzy 40 Tablet (15) cannot treat any kind of mental disorder.
Interaction between Food and Tellzy 40 Tablet (15)
Tellzy 40 Tablet (15) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Tellzy 40 Tablet (15)
Consuming Tellzy 40 Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
